A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005-2007

AIDS

Volumn 26, Issue 18, 2012, Pages 2307-2314

  Meiring, Susan T ^a   Quan, Vanessa C ^a   Cohen, Cheryl ^a,b   Dawood, Halima ^c   Karstaedt, Alan S ^b,d   McCarthy, Kerrigan M ^e   Whitelaw, Andrew C ^f   Govender, Nelesh P ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c GREY'S HOSPITAL   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e AURUM INSTITUTE   (South Africa)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

cryptococcal meningitis; Cryptococcus neoformans; HIV; opportunistic infections; paediatric; South Africa; sub Saharan Africa

Indexed keywords

AMPHOTERICIN B; INDIAN INK;

ADOLESCENT; ADULT; ARTICLE; BLOOD CULTURE; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FEMALE; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEX DISTRIBUTION; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 84870239017     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283570567     Document Type: Article

References (31)

1. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L, Niang R, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001;107:E66.
2. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999;179:449-454. (Pubitemid 29086648)
3. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS:100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995;8:515-548.
4. Currie BP, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 1994;19:1029-1033. (Pubitemid 24380013)
5. McCarthy KM, Morgan J, Wannemuehler KA, Mirza SA, Gould SM, Mhlongo N, et al. Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS 2006;20:2199-2206. (Pubitemid 44684711)
6. Joshi NS, Fisher BT, Prasad PA, Zaoutis TE. Epidemiology of cryptococcal infection in hospitalized children. Pediatr Infect Dis J 2010;29:e91-e95.
7. Gumbo T, Kadzirange G, Mielke J, Gangaidzo IT, Hakim JG. Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2002;21:54-56. (Pubitemid 34073960)
8. Abadi J, Nachman S, Kressel AB, Pirofski L. Cryptococcosis in children with AIDS. Clin Infect Dis 1999;28:309-313. (Pubitemid 29241220)
9. Huang KY, Huang YC, Hung IJ, Lin TY. Cryptococcosis in nonhuman immunodeficiency virus-infected children. Pediatr Neurol 2010;42:267-270.
10. Laman M, Hwaihwanje I, Davis TM, Manning L. Cryptococcal meningitis in immunocompetent Papua New Guinean children. Trop Doct 2010;40:61-63.
11. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003;36:789-794. (Pubitemid 36337986)
12. Likasitwattanakul S, Poneprasert B, Sirisanthana V. Cryptococcosis in HIV-infected children. Southeast Asian J Trop Med Public Health 2004;35:935-939. (Pubitemid 40143415)
13. Mullan PC, Steenhoff AP, Draper H, Wedin T, Bafana M, Anabwani G, et al. Etiology of meningitis among patients admitted to a tertiary referral hospital in Botswana. Pediatr Infect Dis J 2011;30:620-622.
14. Severo CB, Xavier MO, Gazzoni AF, Severo LC. Cryptococcosis in children. Paediatr Respir Rev 2009;10:166-171.
15. Davis J, Zheng WY, Glatman-Freedman A, Ng JA, Pagcatipunan MR, Lessin H, et al. Serologic evidence for regional differences in pediatric cryptococcal infection. Pediatr Infect Dis J 2007;26:549-551. (Pubitemid 46847323)
16. Kaur R, Mittal N, Rawat D, Mathur MD. Cryptococcal meningitis in a neonate. Scand J Infect Dis 2002;34:542-543.
17. Castro G, Cervi MC, Martinez R. Vertical transmission of Cryptococcus neoformans from a mother coinfected with human immunodeficiency virus: case report. Rev Soc Bras Med Trop 2006;39:501-503. (Pubitemid 44916048)
18. Min KH, Kwon-Chung KJ. The biochemical basis for the distinction between the two Cryptococcus neoformans varieties with CGB medium. Zentralbl Bakteriol Mikrobiol Hyg A 1986;261:471-480.
19. Govender NP, Patel J, van Wyk M, Chiller TM, Lockhart SR. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008. Antimicrob Agents Chemother 2011;55:2606-2611.
20. Statistics South Africa. P0302: mid-year population estimates, South Africa. 2005. http://www.statssa.gov. za/publications. [Accessed 21 November 2011]
21. Actuarial Society of South Africa AIDS Committee. ASSA2003 AIDS and demographic model. 2005. http://aids.actuarialsocie ty.org.za/ASSA2003-model- 3165.htm. [Accessed 21 November 2011]
22. Meiring S, Cohen C, Govender N, Keddy K, Msimang V, Quan V, et al. Bacterial and fungal meningitis in children <5 years of age, South Africa, 2007 [abstract]. South Afr J Epidemiol Infect 2009;24:30.
23. Rabie H, Marais B, Cotton M. Preventing and diagnosing HIV infection in infants and chilren. SA Fam Pract 2006;48:34-41. (Pubitemid 44600262)
24. World Health Organization (WHO). Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS case definitions for surveillance (African region). www.who.int/hiv/pub/guidelines/clini calstaging.pdf. [Accessed 21 November 2011]
25. Morgan J, McCarthy KM, Gould S, Fan K, Arthington-Skaggs B, Iqbal N, et al. Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin Infect Dis 2006;43:1077-1080. (Pubitemid 44631112)
26. South African Department of Health. Policy and guidelines for the implementation of the PMTCT programme. 2008. www.doh.gov. za. [Accessed 21 November 2011]
27. Horwood C, Butler L, Haskins L, Phakathi S, Rollins N. 6 week PMTCT surveillance: measuring the impact of the prevention of mother-to-child HIV transmission (PMTCT) programme in KwaZulu-Natal, South Africa [abstract]. http://pag.ias2011.org/abstracts.aspx?aid=3957. [Accessed 21 November 2011]
28. Actuarial Society of South Africa AIDS Committee. Initial observations on the comparison of the 2005 HSRC household HIV prevalence and behaviour survey amongst estimates from the ASSA2003 AIDS and demographic model. www.actuarial society.org.za. [Accessed 21 November 2011]
29. McCarthy KM, Meintjes G, Arthington-Skaggs B, Bicanic T, Cotton M, Chiller T, et al. Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients. S Afr J HIV Med 2007; Spring: 25-35.
30. Park BJ, Shetty S, Ahlquist A, Greenbaum A, Miller JL, Motsi A, et al. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the preantiretroviral therapy era, Gauteng Province, South Africa. Int J STD AIDS 2011;22:199-203.
31. Jarvis JN, Harrison TS, Govender N, Lawn SD, Longley N, Bicanic T, et al. Routine cryptococcal antigen screening for HIV-infected patients with low CD4R T-lymphocyte counts: time to implement in South Africa?. S Afr Med J 2011;101:232-234.